CSF-1R promotes vasculogenic mimicry via epithelial-mesenchymal transition in nasopharyngeal carcinoma cells
Author:
Mo Huaqing1, Lv Yanru1, Gao Shan1, Chen Zenan1, Xu Zhiyong1, Shen Jingyi1, Zhou Shu1, Yin Mengjie1, Xie Yanyan1, Hao Yanrong1
Affiliation:
1. Cancer Center, The People’s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences , Nanning , Guangxi , P.R. China
Abstract
Abstract
Objectives
In nasopharyngeal carcinoma (NPC), the main factors for treatment failure are local recurrence and metastasis. Vasculogenic mimicry (VM), formation by invasive cancer cells mimicking the vasculogenic network, is strongly correlated with tumor therapy resistance and distant metastasis. CSF-1R was substantially expressed in NPC patients with a poor prognosis, according to an earlier study of ours. However, whether CSF-1R affects progression through vasculogenic mimicry deserves consideration.
Methods
By cultivating NPC cells that had CSF-1R overexpression in three-dimensional culture and labeling the NPC xenografts with CD34-PAS vasculogenic mimicry markers, the effect of CSF-1R on VM formation, migration, and invasion of NPC cells was evaluated. Finally, the underlying mechanisms were investigated by western blot.
Results
In vitro and in vivo, overexpressing CSF-1R in NPC cells causes the development of vessel-like structures. Meanwhile, NPC cells migrated and invaded more readily in the Transwell experiment when CSF-1R was highly expressed. Mechanistically, our research indicates that CSF-1R may control cell plasticity by activating the PI3K/AKT signaling pathway, promoting the formation of VM in these cells by facilitating the epithelial-mesenchymal transition.
Conclusions
CSF-1R in NPC progression by increasing VM production to increase nutrient supply to tumor cells and promote cancer cell invasion. Furthermore, these findings suggest that CSF-1R is a new promising therapeutic target aimed at treating VM in NPC.
Funder
National Natural Science Foundation of China Key Research and Development Program of Guangxi
Publisher
Walter de Gruyter GmbH
Reference57 articles.
1. Chen, YP, Chan, ATC, Le, QT, Blanchard, P, Sun, Y, Ma, J. Nasopharyngeal carcinoma. Lancet 2019;394:64–80. https://doi.org/10.1016/s0140-6736(19)30956-0. 2. Guo, R, Mao, YP, Tang, LL, Chen, L, Sun, Y, Ma, J. The evolution of nasopharyngeal carcinoma staging. Br J Radiol 2019;92:20190244. https://doi.org/10.1259/bjr.20190244. 3. Lee, AWM, Ng, WT, Chan, JYW, Corry, J, Mäkitie, A, Mendenhall, WM, et al.. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev 2019;79:101890. https://doi.org/10.1016/j.ctrv.2019.101890. 4. Chiang, AK, Mak, NK, Ng, WT. Translational research in nasopharyngeal carcinoma. Oral Oncol 2014;50:345–52. https://doi.org/10.1016/j.oraloncology.2013.11.005. 5. Maniotis, AJ, Folberg, R, Hess, A, Seftor, EA, Gardner, LM, Pe’er, J, et al.. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155:739–52. https://doi.org/10.1016/s0002-9440(10)65173-5.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|